Results of voting at AGMs

Voting on the resolutions put to each AGM is on a poll rather than by a show of hands. The results of the poll are announced to the London Stock Exchange, via the Regulatory Information Service, as soon as practicable after the AGM. They are also published on this page.

Results of AGM

GlaxoSmithKline (GSK) announces that at today's Annual General Meeting all resolutions, including those electing and re-electing Board members, were passed by shareholders.

Commenting on the results Sir Christopher Hogg, Chairman of GlaxoSmithKline said "I'm very pleased that all the resolutions have been passed by such a substantial majority."

The following table shows the votes cast for each resolution:

	Resolution	Total Votes For*	%	Total Votes Against	%	Total Votes Cast	Abstentions **
1.	Adoption of Financial Statements	3,772,569,153	98.61	53,133,367	1.39	3,825,702,520	126,825,561
2.	Approval of the Remuneration Report	3,256,510,243	89.49	382,337,135	10.51	3,638,847,378	314,504,441
3.	Election of Mr H L Culp	3,915,556,226	99.46	21,302,704	0.54	3,936,858,930	15,669,151
4.	Election of Mr C Davis	3,915,875,382	99.46	21,323,427	0.54	3,937,198,809	15,329,272
5.	Election of Sir Robert Wilson	3,916,386,157	99.45	21,552,354	0.55	3,937,938,511	14,589,570
6.	Election of Dr T Yamada	3,861,633,390	99.33	26,051,285	0.67	3,887,684,675	64,843,406
7.	Re-election of Sir Christopher Hogg	3,876,671,124	98.83	45,713,506	1.17	3,922,384,630	30,143,451
8.	Re-appointment of Auditors	3,758,892,246	99.32	25,819,263	0.68	3,784,711,509	167,816,572
9.	Remuneration of Auditors	3,918,517,277	99.48	20,305,032	0.52	3,938,822,309	13,705,772
10.	Authorise donations to EU Political Organisations and incur EU Political Expenditure	3,843,373,653	97.99	78,986,180	2.01	3,922,359,833	30,168,248
11.	Disapplication of pre-emption rights***	3,904,964,468	99.00	39,246,915	1.00	3,944,211,383	8,316,698
12.	Authority for the Company to purchase its own shares***	3,882,768,808	99.45	21,328,838	0.55	3,904,097,646	48,430,435

* Includes discretionary votes.
** An abstention is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.
*** Indicates Special Resolutions requiring a 75% majority

The following table provides further relevant information:

	GlaxoSmithKline's Fourth AGM (2004)	GlaxoSmithKline's Third AGM (2003)
Issued share capital (excluding Treasury Shares)	5,921,564,431	6,001,763,774
Total votes cast and abstentions lodged as a % of GSK's issued share capital (excluding Treasury Shares).	66.75%	63.23%
Total shareholder population.	230,939	241,420
Total number of proxies lodged.	17,400	18,560
% of shareholders who lodged proxies.	7.53%	7.69%
Number of shareholders, corporate representatives and proxies who attended the AGM	349	532

S M Bicknell
Company Secretary
17th May 2004